Trials / Recruiting
RecruitingNCT04556214
Liver Transplantation for Non-Resectable Intrahepatic Cholangiocarcinoma: a Prospective Exploratory Trial (TESLA Trial)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Oslo University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study will investigate whether liver transplantation provides increased survival, low side effects and good quality of life in patients with bile duct cancer where the tumor cannot be removed by normal surgery. Analyzes of blood and tissue samples from the tumor will be investigated to see if the analyzes can indicate who may have recurrence of the disease after liver transplantation. Furthermore, the effect of chemotherapy on normal liver and tumor tissues in the liver that are removed during transplantation will be investigated..
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Liver Transplant | Liver Transplant |
Timeline
- Start date
- 2020-06-01
- Primary completion
- 2035-05-31
- Completion
- 2035-05-31
- First posted
- 2020-09-21
- Last updated
- 2023-04-11
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT04556214. Inclusion in this directory is not an endorsement.